COREY ALBANESE: Open Payments
NPI 1841885746 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,259 in 189 payments from 28 companies in 2025. Trend: 2023 $3,225 · 2024 $3,279 · 2025 $3,259
Food & beverage: $3,259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $507 |
| UCB, Inc. | 17 | $288 |
| SK Life Science, Inc. | 13 | $268 |
| Lilly USA, LLC | 8 | $248 |
| Neurelis, Inc. | 9 | $233 |
| Genentech USA, Inc. | 8 | $185 |
| Lundbeck LLC | 11 | $182 |
| Teva Pharmaceuticals USA, Inc. | 13 | $175 |
| ARGENX US, INC. | 8 | $143 |
| JAZZ PHARMACEUTICALS INC. | 10 | $141 |
Products named: VALTOCO, Ocrevus Zunovo, AUSTEDO XR, VYEPTI, VRAYLAR, EPIDIOLEX, NURTEC ODT, QULIPTA.
Industry payments across NJ — which companies pay providers there.
